These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 1980841)
1. Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Seniuk NA; Tatton WG; Greenwood CE Brain Res; 1990 Sep; 527(1):7-20. PubMed ID: 1980841 [TBL] [Abstract][Full Text] [Related]
2. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss. Alam G; Edler M; Burchfield S; Richardson JR Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118 [TBL] [Abstract][Full Text] [Related]
3. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. Tatton WG; Greenwood CE J Neurosci Res; 1991 Dec; 30(4):666-72. PubMed ID: 1686284 [TBL] [Abstract][Full Text] [Related]
4. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Jackson-Lewis V; Jakowec M; Burke RE; Przedborski S Neurodegeneration; 1995 Sep; 4(3):257-69. PubMed ID: 8581558 [TBL] [Abstract][Full Text] [Related]
5. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice. Muthane U; Ramsay KA; Jiang H; Jackson-Lewis V; Donaldson D; Fernando S; Ferreira M; Przedborski S Exp Neurol; 1994 Apr; 126(2):195-204. PubMed ID: 7925820 [TBL] [Abstract][Full Text] [Related]
6. Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice. Chang FW; Wang SD; Lu KT; Lee EH Brain Res Bull; 1993; 31(3-4):253-66. PubMed ID: 7683960 [TBL] [Abstract][Full Text] [Related]
7. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. Zhang J; Graham DG; Montine TJ; Ho YS J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035 [TBL] [Abstract][Full Text] [Related]
8. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB/c mice. Hu SC; Chang FW; Sung YJ; Hsu WM; Lee EH J Pharmacol Exp Ther; 1991 Dec; 259(3):1379-87. PubMed ID: 1684822 [TBL] [Abstract][Full Text] [Related]
9. Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta). Shughrue PJ Exp Neurol; 2004 Dec; 190(2):468-77. PubMed ID: 15530885 [TBL] [Abstract][Full Text] [Related]
10. Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry. Schneider JS; Markham CH Brain Res; 1986 May; 373(1-2):258-67. PubMed ID: 2872936 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice. Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781 [TBL] [Abstract][Full Text] [Related]
12. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058 [TBL] [Abstract][Full Text] [Related]
13. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons. Rothblat DS; Schneider JS Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679 [TBL] [Abstract][Full Text] [Related]
14. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice. Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotection in Parkinson models varies with toxin administration protocol. Anderson DW; Bradbury KA; Schneider JS Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378 [TBL] [Abstract][Full Text] [Related]
16. Ultrastructural changes of the substantia nigra, ventral tegmental area and striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Mizukawa K; Sora YH; Ogawa N Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):307-20. PubMed ID: 2343182 [TBL] [Abstract][Full Text] [Related]
17. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice. Mitsumoto Y; Watanabe A; Mori A; Koga N Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982 [TBL] [Abstract][Full Text] [Related]